Viewing Study NCT04028518


Ignite Creation Date: 2025-12-25 @ 4:32 AM
Ignite Modification Date: 2026-01-16 @ 9:29 PM
Study NCT ID: NCT04028518
Status: UNKNOWN
Last Update Posted: 2019-07-22
First Post: 2019-06-13
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phaseâ…¡ of Injection for Recombinant Human Tissue Plasminogen Kinase Derivative in Treatment of Acute Ischemic Stroke.
Sponsor: Angde Biotech Pharmaceutical Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module